Hims & Hers Health Inc. (NYSE:HIMS) Under Investigation: A Financial Overview

Berger Montague investigates NYSE:HIMS for potential breaches of fiduciary duties following the end of a partnership with Novo Nordisk.Chief Commercial Officer Chi Michael sold 13,749 shares amid ongoing legal scrutiny, raising questions about insider confidence.HIMS's financial metrics, including a P/E ratio of 67.01 and a current ratio of 4.98, reflect investor expectations and the company's ability to cover short-term liabilities.Hims & Hers Health Inc. (NYSE:HIMS) is under scrutiny as Berger Montague, a ...